General Information of Drug (ID: DM9LUTV)

Drug Name
RXC006 Drug Info
Synonyms AZD5055
Indication
Disease Entry ICD 11 Status REF
Idiopathic pulmonary fibrosis CB03.4 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM9LUTV

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ETC-1922159 DMY0HU6 Solid tumour/cancer 2A00-2F9Z Phase 1 [3]
LGK974 DMAG6BV Solid tumour/cancer 2A00-2F9Z Phase 1 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Protein-serine O-palmitoleoyltransferase porcupine (PORCN) TTNFBTO PORCN_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT05134727) A Double-blind, Randomized, Placebo-controlled Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of Oral AZD5055 Following Single and Multiple Ascending Doses. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Redx
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)